| Style | Citing Format |
|---|---|
| MLA | Naijian R, et al.. "Benchmarking Molecular Fingerprints and Vector Embeddings for Predicting Indoleamine and Tryptophan-2,3-Dioxygenase Inhibition Selectivity." Letters in Drug Design and Discovery, vol. 23, no. 6, 2026, pp. -. |
| APA | Naijian R, Valipour M, Amini M, Irannejad H (2026). Benchmarking Molecular Fingerprints and Vector Embeddings for Predicting Indoleamine and Tryptophan-2,3-Dioxygenase Inhibition Selectivity. Letters in Drug Design and Discovery, 23(6), -. |
| Chicago | Naijian R, Valipour M, Amini M, Irannejad H. "Benchmarking Molecular Fingerprints and Vector Embeddings for Predicting Indoleamine and Tryptophan-2,3-Dioxygenase Inhibition Selectivity." Letters in Drug Design and Discovery 23, no. 6 (2026): -. |
| Harvard | Naijian R et al. (2026) 'Benchmarking Molecular Fingerprints and Vector Embeddings for Predicting Indoleamine and Tryptophan-2,3-Dioxygenase Inhibition Selectivity', Letters in Drug Design and Discovery, 23(6), pp. -. |
| Vancouver | Naijian R, Valipour M, Amini M, Irannejad H. Benchmarking Molecular Fingerprints and Vector Embeddings for Predicting Indoleamine and Tryptophan-2,3-Dioxygenase Inhibition Selectivity. Letters in Drug Design and Discovery. 2026;23(6):-. |
| BibTex | @article{ author = {Naijian R and Valipour M and Amini M and Irannejad H}, title = {Benchmarking Molecular Fingerprints and Vector Embeddings for Predicting Indoleamine and Tryptophan-2,3-Dioxygenase Inhibition Selectivity}, journal = {Letters in Drug Design and Discovery}, volume = {23}, number = {6}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Naijian R AU - Valipour M AU - Amini M AU - Irannejad H TI - Benchmarking Molecular Fingerprints and Vector Embeddings for Predicting Indoleamine and Tryptophan-2,3-Dioxygenase Inhibition Selectivity JO - Letters in Drug Design and Discovery VL - 23 IS - 6 SP - EP - PY - 2026 ER - |